|
NEDD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.75979999858822E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.95340000000532E-06 |
| Normal-vs-Stage2 |
5.74119999999789E-05 |
| Normal-vs-Stage3 |
1.70989999936921E-08 |
| Normal-vs-Stage4 |
5.93969999962418E-07 |
| Stage1-vs-Stage2 |
4.936800E-01 |
| Stage1-vs-Stage3 |
7.052200E-02 |
| Stage1-vs-Stage4 |
1.277640E-01 |
| Stage2-vs-Stage3 |
5.522000E-01 |
| Stage2-vs-Stage4 |
5.241000E-01 |
| Stage3-vs-Stage4 |
8.722200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.79659999988147E-07 |
| Normal-vs-AfricanAmerican |
1.859420E-03 |
| Normal-vs-Asian |
2.156900E-04 |
| Caucasian-vs-AfricanAmerican |
7.559600E-01 |
| Caucasian-vs-Asian |
7.185400E-01 |
| AfricanAmerican-vs-Asian |
9.712600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.84549999954409E-07 |
| Normal-vs-Female |
1.4313999996407E-07 |
| Male-vs-Female |
7.775600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.69634999999113E-05 |
| Normal-vs-Age(41-60Yrs) |
1.74730000024326E-07 |
| Normal-vs-Age(61-80Yrs) |
6.93039999832834E-08 |
| Normal-vs-Age(81-100Yrs) |
4.641500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.835210E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.400170E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.614800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.622000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.780400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.493400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.858640E-01 |
| Classical-VS-Follicular |
1.169950E-01 |
| Classical-VS-Other |
3.798000E-01 |
| Classical-VS-Normal |
2.21320000004521E-06 |
| Tall-VS-Follicular |
9.008000E-01 |
| Tall-VS-Other |
8.555600E-01 |
| Tall-VS-Normal |
5.94959999999922E-05 |
| Follicular-VS-Other |
8.196200E-01 |
| Follicular-VS-Normal |
3.47990000004739E-06 |
| Other-VS-Normal |
1.118500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.0995999978376E-08 |
| Normal-vs-N1 |
1.66660000022745E-07 |
| N0-vs-N1 |
5.310000E-01 |
|
|
